A new class of non-opioid drugs treats pain by blocking signals before they reach the brain, reducing the risk of addiction.

The US Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

US FDA has approved its first ever non-opioid painkiller called suzetrigine. Experts believe it will prevent addiction ...

However, the findings also show decreases in opioid outcomes after medical ... Researchers 'See' Vulnerability to Gaming Addiction in the Adolescent Brain Dec. 9, 2024 — Researchers found ...

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

Will people with acute pain want a new painkiller whose list price is $15.50 a pill when a generic prescription drug is at ...

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...